Primary record
Zolmitriptan; (4S)-4-[[3-[2-Dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one; (S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone; 311C90; Asco Top; BW 311C90; Xolnox; Zipton; Zomig; Zominat
- 库存
- 3,300 克
- 纯度
- 98.6 %
- CAS
- 139264-17-8
化合物标识与属性
- CAS
- 139264-17-8
- PubChem CID
- 60857
- SMILES
- CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3
- Canonical SMILES
- CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12
名称与同义词
- zolmitriptan
- Zomig
- Zomigoro
- 139264-17-8
- Zomigon
- Flezol
- Zomig-ZMT
- AscoTop
- zolmitriptanum
- AscoTopand
- zipton
- zolmitriptane
- zominat
- Rapimelt
- Zomig Nasal Spray
- Zomig ZMT
- Zolmiptriptan
- Zolmitriptan [USAN]
- Zolmitriptan OD
- Zolmitriptan CRS
- Zomig RM
- Zomig-RM
- Zomig (TN)
- Zolmitriptan RapidFilm
- Zomigoro (TN)
- Zomigon (TN)
- AscoTop (TN)
- Zolmitriptan (Zomig)
- Cvt-427
- 2FS66TH3YW
- 311C90
- ZOLMITRIPTAN 1G
- RefChem:57200
- UNII-2FS66TH3YW
- Spectrum2_000728
- CHEMBL1185
- ZOLMITRIPTAN [MI]
- C16H21N3O2
- DTXSID8045933
- ZOLMITRIPTAN [INN]
- ZOLMITRIPTAN [JAN]
- D0NG7O
- GTPL60
- AC1L1U2E
- ZOLMITRIPTAN 200MG
- Zolmitriptan [USAN:INN:BAN]
- ZOLMITRIPTAN [VANDF]
- BW-311C90
- MFCD00871503
- SCHEMBL33336
- DTXCID6025933
- ZOLMITRIPTAN [MART.]
- CHEBI:10124
- MLS000758208
- MLS001424172
- BIDD:GT0040
- NSC-760383
- SPECTRUM1505281
- ZOLMITRIPTAN [USP-RS]
- ZOLMITRIPTAN [WHO-DD]
- SPBio_000656
- Zolmitriptan (JAN/USP/INN)
- ULSDMUVEXKOYBU-ZDUSSCGKSA-N
- orb1309803
- SCHEMBL29356689
- ERK5-1N22
- KS-00000HAJ
- ZINC15515
- Zolmitriptan - Bio-X trade mark
- N02CC03
- Zolmitriptan, >=98% (HPLC)
- Zomig;Zomigon;AscoTopand;Zomigoro
- GLXC-05182
- HMS1922B04
- HMS2052K17
- HMS2093O14
- HMS2235I22
- HMS3714H11
- HMS3884A06
- Pharmakon1600-01505281
- ZOLMITRIPTAN [ORANGE BOOK]
- ZOLMITRIPTAN [EP MONOGRAPH]
- ACT04392
- BCP10513
- CID60857
- HY-B0229
- KS-5072
- Tox21_111455
- ZOLMITRIPTAN [USP MONOGRAPH]
- BDBM50033383
- CCG-38993
- CID:60857
- EBC-26462
- HB1801
- MSK168257
- NP3176
- NSC760383
- s1649
- AKOS015850706
- C16-H21-N3-O2
- Tox21_111455_1
- ACN-048280
- AN-5272
- AT-3239
- CS-2179
- DB00315
- FZ28774
- NC00382
- NSC 760383
- (S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one
- NCGC00095155-01
- NCGC00263884-02
- NCGC00263884-03
- NCGC00263884-08
- BC206232
- BZ164590
- CPD000449310
- SAM001246841
- SAM001247064
- SC-17326
- SID:96099961
- SMR000449310
- SY057937
- 311-C-90
- BW-311C90;311C90
- SBI-0206762.P001
- (4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one
- 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone
- AB2000194
- J694.097H
- LS-100559
- ST2407794
- (S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one
- B2261
- CAS-139264-17-8
- SW197762-2
- Z0024
- 2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-
- (S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone
- 64Z178
- A-2479
- C07218
- D00415
- J10141
- AB00698244-05
- AB00698244_06
- C089750
- EN300-18567396
- Q218820
- SR-05000001693
- 2-Oxazolidinone, 4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-, (S)-
- SR-05000001693-1
- Zolmitriptan =98.0% (by HPLC, titration analysis)
- Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan
- (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one
- (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone
- 4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one
- BRD-K54314721-001-09-4
- BRD-K54314721-001-10-2
- (4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone
- (4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone
- (S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone
- (4S)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one
- (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one
- (S)-4-[[3-[2-(Dimethylamino)ethyl]-5-indolyl]methyl]oxazolidin-2-one
- (S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl]ethylamine
- Zolmitriptan, United States Pharmacopeia (USP) Reference Standard
- (4R)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one
- (S)-4-({3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl}methyl)oxazolidin-2-one
- (S)-4-[[3-[2-(Dimethylamino)ethyl]indol-5-yl]methyl]-2-oxazolidinone
- (s)-4-{3-[2-(dimethylamino)ethyl]-1h-indol-5-ylmethyl}oxazolidin-2-one
- 4-((3-(2-dimethylaminoethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one
- Zolmitriptan, 98%, a selective 5-HT1B/1D/1F receptor agonist - 1G 1g
- (4S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-1,3-oxazolidin-2-one
- (4S)-4-((3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-5-YL)METHYL)-2-OXAZOLIDINONE
- (4S)-4-((3-(2-dimethylaminoethyl)-1H-indol-5-yl)methyl)-1,3-oxazolidin-2-one
- (4S)-4beta-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one
- (S) -N,N-Dimethyl-2- [5- (2-oxo-1,3-oxazolidin-4-ylmethyl) -1H -indol-3-yl]ethylamine
- (S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-1,3-oxazolidin-2-one
- (S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one
- (S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H -indol-3-yl]ethylamine
- 2-Oxazolidinone, 4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-,(S)-
- 139264-25-8
- 629-919-0
- TRZ
- ZMT
- Zolmitriptan; (4S)-4-[[3-[2-Dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one; (S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone; 311C90; Asco Top; BW 311C90; Xolnox; Zipton; Zomig; Zominat